GFL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 11:30 am

Quick Insight

GFL Ltd, operating in the organic chemicals sector, currently trades at ₹61.9 with a market capitalization of ₹680 crore. The company exhibits a troubling performance, evidenced by a negative net profit of ₹76 crore and an alarming operating profit margin of -2,543%. With a return on equity (ROE) of just 2.96% and return on capital employed (ROCE) at 1.89%, the firm struggles to generate shareholder value, especially with a price-to-book value (P/BV) ratio of 0.28x indicating significant undervaluation relative to its reserves of ₹2,510 crore. The absence of borrowings (₹0 crore) suggests a conservative financial approach, yet the lack of interest coverage (ICR 0.00x) raises red flags regarding its ability to sustain operations. Despite 68.72% promoter ownership, the low foreign institutional investment (FIIs 0.23%) and modest domestic institutional investment (DIIs 2.05%) reflect a lack of confidence from external investors. In conclusion, while GFL Ltd's low valuation may attract bargain hunters, the concerning financial metrics warrant caution and a thorough evaluation of its operational viability before considering an investment.

Competitors of GFL Ltd

All Competitor Stocks of GFL Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:11 am

Below is a detailed analysis of the quarterly data for GFL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Expenses, as of Mar 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Dec 2024) to 22.00 Cr., marking an increase of 22.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Dec 2024) to -21.00 Cr., marking a decrease of 21.00 Cr..
• For OPM %, as of Mar 2025, the value is -2,543.00%. The value appears to be declining and may need further review. It has decreased from 52.00% (Dec 2024) to -2,543.00%, marking a decrease of 2,595.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 5.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to -21.00 Cr., marking a decrease of 26.00 Cr..
• For Tax %, as of Mar 2025, the value is -14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Dec 2024) to -14.00%, marking a decrease of 29.00%.
• For Net Profit, as of Mar 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to -18.00 Cr., marking a decrease of 23.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.66. The value appears to be declining and may need further review. It has decreased from 0.42 (Dec 2024) to -1.66, marking a decrease of 2.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:29 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:06 pm

Below is a detailed analysis of the balance sheet data for GFL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,510.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,583.00 Cr. (Mar 2024) to 2,510.00 Cr., marking a decrease of 73.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 165.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Mar 2024) to 165.00 Cr., marking an increase of 27.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,686.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,732.00 Cr. (Mar 2024) to 2,686.00 Cr., marking a decrease of 46.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 2,650.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,696.00 Cr. (Mar 2024) to 2,650.00 Cr., marking a decrease of 46.00 Cr..
• For Other Assets, as of Mar 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2024) to 33.00 Cr., marking a decrease of 1.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,686.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,732.00 Cr. (Mar 2024) to 2,686.00 Cr., marking a decrease of 46.00 Cr..

Notably, the Reserves (2,510.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for GFL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 203.46 (Mar 23) to -0.69, marking a decrease of 204.15.
• For Diluted EPS (Rs.), as of Mar 24, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 203.46 (Mar 23) to -0.69, marking a decrease of 204.15.
• For Cash EPS (Rs.), as of Mar 24, the value is 0.25. This value is below the healthy minimum of 3. It has decreased from 208.49 (Mar 23) to 0.25, marking a decrease of 208.24.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 236.16. It has decreased from 236.85 (Mar 23) to 236.16, marking a decrease of 0.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 236.16. It has decreased from 236.85 (Mar 23) to 236.16, marking a decrease of 0.69.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.29. There is no change compared to the previous period (Mar 23) which recorded 0.29.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.20. This value is below the healthy minimum of 2. It has increased from 0.09 (Mar 23) to 0.20, marking an increase of 0.11.
• For PBIT / Share (Rs.), as of Mar 24, the value is 0.19. This value is within the healthy range. It has increased from 0.09 (Mar 23) to 0.19, marking an increase of 0.10.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.19. This value is within the healthy range. It has decreased from 223.15 (Mar 23) to 0.19, marking a decrease of 222.96.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 208.49 (Mar 23) to 0.25, marking a decrease of 208.24.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -0.68. This value is below the healthy minimum of 2. It has decreased from 204.68 (Mar 23) to -0.68, marking a decrease of 205.36.
• For PBDIT Margin (%), as of Mar 24, the value is 69.42. This value is within the healthy range. It has increased from 32.73 (Mar 23) to 69.42, marking an increase of 36.69.
• For PBIT Margin (%), as of Mar 24, the value is 68.76. This value exceeds the healthy maximum of 20. It has increased from 32.13 (Mar 23) to 68.76, marking an increase of 36.63.
• For PBT Margin (%), as of Mar 24, the value is 68.76. This value is within the healthy range. It has decreased from 76,025.87 (Mar 23) to 68.76, marking a decrease of 75,957.11.
• For Net Profit Margin (%), as of Mar 24, the value is 87.90. This value exceeds the healthy maximum of 10. It has decreased from 71,029.76 (Mar 23) to 87.90, marking a decrease of 70,941.86.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -236.93. This value is below the healthy minimum of 8. It has decreased from 69,732.26 (Mar 23) to -236.93, marking a decrease of 69,969.19.
• For Return on Networth / Equity (%), as of Mar 24, the value is -0.29. This value is below the healthy minimum of 15. It has decreased from 86.41 (Mar 23) to -0.29, marking a decrease of 86.70.
• For Return on Capital Employeed (%), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 10. It has increased from 0.03 (Mar 23) to 0.08, marking an increase of 0.05.
• For Return On Assets (%), as of Mar 24, the value is -0.27. This value is below the healthy minimum of 5. It has decreased from 82.02 (Mar 23) to -0.27, marking a decrease of 82.29.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Current Ratio (X), as of Mar 24, the value is 64.27. This value exceeds the healthy maximum of 3. It has increased from 32.34 (Mar 23) to 64.27, marking an increase of 31.93.
• For Quick Ratio (X), as of Mar 24, the value is 64.27. This value exceeds the healthy maximum of 2. It has increased from 32.34 (Mar 23) to 64.27, marking an increase of 31.93.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 1,507.86 (Mar 23) to 0.00, marking a decrease of 1,507.86.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -194,803.71 (Mar 23) to 0.00, marking an increase of 194,803.71.
• For Enterprise Value (Cr.), as of Mar 24, the value is 744.31. It has increased from 523.17 (Mar 23) to 744.31, marking an increase of 221.14.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 232.99. This value exceeds the healthy maximum of 3. It has increased from 162.26 (Mar 23) to 232.99, marking an increase of 70.73.
• For EV / EBITDA (X), as of Mar 24, the value is 335.58. This value exceeds the healthy maximum of 15. It has decreased from 495.66 (Mar 23) to 335.58, marking a decrease of 160.08.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 233.38. This value exceeds the healthy maximum of 3. It has increased from 162.65 (Mar 23) to 233.38, marking an increase of 70.73.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 23) to 0.28, marking an increase of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 233.39. This value exceeds the healthy maximum of 3. It has increased from 162.66 (Mar 23) to 233.39, marking an increase of 70.73.
• For EarningsYield, as of Mar 24, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 4.29 (Mar 23) to -0.01, marking a decrease of 4.30.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness